The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of HER2 and ErbB3 molecular alterations with afatinib sensitivity in platinum-refractory metastatic urothelial carcinoma (UC) in a phase II trial.
 
Noura Choudhury
No Relationships to Disclose
 
Alexa Campanile
No Relationships to Disclose
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Celgene; Seagen
 
Tatjana Antic
No Relationships to Disclose
 
Walter Michael Stadler
Honoraria - Bayer; CVS Caremark; Dendreon; Johnson & Johnson; medpacto; Merck; Millennium; Novartis; Roche/Genentech; Veridex
Consulting or Advisory Role - Bayer; CVS Caremark; Dendreon; Genentech/Roche; Medivation; medpacto; Millennium; Novartis; Sotio; Veridex
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly/ImClone (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst)
Other Relationship - UpToDate
 
Yusuke Nakamura
No Relationships to Disclose
 
Peter H. O'Donnell
Stock and Other Ownership Interests - DaVita
Honoraria - Indiana University; OptumHealth; University of Florida
Consulting or Advisory Role - Abbott Molecular; Advanced Medical; Algeta ASA; Dendreon
Research Funding - Boston Biomedical; Dendreon; Genentech; Merck
Patents, Royalties, Other Intellectual Property - Genomic Prescribing System
Travel, Accommodations, Expenses - Sequenom